Coherus Oncology (CHRS) Stock Chart & Stock Price History $1.07 +0.02 (+1.90%) Closing price 04:00 PM EasternExtended Trading$1.06 -0.01 (-0.47%) As of 04:28 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Coherus Oncology Stock Price Performance The Coherus Oncology (CHRS) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 15.08%, with a year-to-date return of -22.46%. In the past month, the stock has increased 21.48%, reflecting recent market activity. As of the latest close, Coherus Oncology traded at $1.05 with a market cap of $121.73 million and volume of 1.65 million shares. Five years ago, the stock traded at $19.50, representing a 94.51% decrease over that period. At the time, it had a market cap of $1.39 billion and a volume of 1.14 million shares. Receive CHRS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Coherus Oncology and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+7.11%1 Month Performance+21.48%3 Month Performance+40.60%Year-To-Date Performance-22.46%1 Year Performance-15.08%5 Year Performance-94.51% CHRS Stock Chart for Monday, August, 18, 2025 CHRS Chart by TradingView Coherus Oncology Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/15/2025$1.02$1.05+2.94%$1.06$1.021.65 million shs$121.73 million08/14/2025$1.00$1.02+2.10%$1.04$0.95971,515 shs$118.25 million08/13/2025$0.92$1.00+9.07%$1.00$0.921.53 million shs$115.81 million08/12/2025$0.88$0.92+4.04%$0.92$0.88970,812 shs$106.18 million08/11/2025$0.82$0.88+7.35%$0.89$0.831.13 million shs$102.06 million08/08/2025$0.88$0.82-7.23%$0.90$0.811.86 million shs$95.07 million08/07/2025$0.92$0.88-3.47%$0.94$0.881.70 million shs$102.47 million08/06/2025$0.91$0.92+0.60%$0.94$0.89986,410 shs$106.16 million08/05/2025$0.87$0.91+4.86%$0.95$0.881.11 million shs$105.52 million08/04/2025$0.88$0.87-1.12%$0.92$0.86959,739 shs$100.63 million Get the Latest News and Ratings for CHRS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Coherus Oncology and its competitors with MarketBeat's FREE daily newsletter. 08/01/2025$0.94$0.88-6.64%$0.95$0.841.96 million shs$101.76 million07/31/2025$0.97$0.94-3.07%$1.02$0.931.29 million shs$109.00 million07/30/2025$1.01$0.97-3.96%$1.04$0.951.45 million shs$112.46 million07/29/2025$1.07$1.01-5.61%$1.09$0.991.60 million shs$117.09 million07/28/2025$1.04$1.07+2.88%$1.15$1.052.48 million shs$124.05 million07/25/2025$1.02$1.04+1.96%$1.05$0.982.00 million shs$120.57 million07/24/2025$0.98$1.02+4.23%$1.06$0.972.10 million shs$118.25 million07/23/2025$0.92$0.98+6.10%$0.99$0.931.33 million shs$113.45 million07/22/2025$0.89$0.92+4.00%$0.93$0.89905,734 shs$106.92 million07/21/2025$0.88$0.89+0.68%$0.94$0.88746,164 shs$102.81 million07/18/2025$0.90$0.88-1.67%$0.93$0.87606,528 shs$102.11 million07/17/2025$0.90$0.90-0.47%$0.94$0.89886,724 shs$103.85 million Related Companies CryoPort Stock Price Chart MBX Biosciences Stock Price Chart Compass Therapeutics Stock Price Chart Esperion Therapeutics Stock Price Chart Astria Therapeutics Stock Price Chart Nanobiotix Stock Price Chart Fulcrum Therapeutics Stock Price Chart Inventiva Stock Price Chart Tonix Pharmaceuticals Stock Price Chart Aura Biosciences Stock Price Chart Receive CHRS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Coherus Oncology and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CHRS) was last updated on 8/18/2025 by MarketBeat.com Staff From Our PartnersBiotech Alert: With news on MPox, RSV, and more, this tiny firm could disrupt a $3B marketA small biotech is stepping into the spotlight with a first-in-class antiviral platform—and it could be one of...Smallcaps Daily | SponsoredFormer CIA Officer Reveals How Gold Saved His Life This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredThe stealth altcoin the financial world is underestimatingThis DeFi project could soar next When altcoin season fully kicks in—which the data suggests is happening R...Crypto 101 Media | SponsoredNew law could create $3.7 trillion tsunami.During a meeting in Washington D.C., Jeff Brown discovered a bold initiative. He calls it “President Trump’...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Coherus Oncology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Coherus Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access